Neuroprotection by agmatine: Possible involvement of the gut microbiome?

Priyanka Saha,Subhrajita Panda,Aayusha Holkar,Rahul Vashishth,Sandeep Singh Rana,Mohanapriya Arumugam,Ghulam Md. Ashraf,Shafiul Haque,Faraz Ahmad

Published 2023 in Ageing Research Reviews

ABSTRACT

Agmatine, an endogenous polyamine derived from L-arginine, elicits tremendous multimodal neuromodulant properties. Alterations in agmatinergic signalling are closely linked to the pathogeneses of several brain disorders. Importantly, exogenous agmatine has been shown to act as a potent neuroprotectant in varied pathologies, including brain ageing and associated comorbidities. The antioxidant, anxiolytic, analgesic, antidepressant and memory-enhancing activities of agmatine may derive from its ability to regulate several cellular pathways; including cell metabolism, survival and differentiation, nitric oxide signalling, protein translation, oxidative homeostasis and neurotransmitter signalling. This review briefly discusses mammalian metabolism of agmatine and then proceeds to summarize our current understanding of the neuromodulation and neuroprotection mediated by agmatine. Further, the emerging exciting bidirectional links between agmatine and the resident gut microbiome and their implications for brain pathophysiology and ageing are also discussed.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-100 of 351 references · Page 1 of 4

CITED BY

Showing 1-27 of 27 citing papers · Page 1 of 1